Skip to main content
geoopen

A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-overexpressing solid tumor malignancies

GEO Series GSE75087. Homo sapiens. 27 samples. Type: Expression profiling by array.

ShareScore

24/100

Overall dataset sharing score

Score breakdown

These five areas show where the dataset supports — or may limit — practical reuse.

Stewardship
4
Harmonization
8
Access
4
Reuse readiness
0
Engagement
8

Topics